Showing 511-520 of 834 results for "".
- UK’s First TransForm Inlay Procedure Performed by Sheraz Daya, MDhttps://modernod.com/news/uks-first-transform-inlay-procedure-performed-by-sheraz-daya-md/2476668/The first patients in the UK have undergone the TransForm Corneal Allograft (TCA) procedure, which was performed by Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth. TCA is a new procedur
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Geoff Tabin, MD, Co-Founder of Global NGO HCP Cureblindness, Steps Into New Rolehttps://modernod.com/news/geoff-tabin-md-co-founder-of-global-ngo-hcp-cureblindness-steps-into-new-role/2482314/Effective immediately, Geoff Tabin, MD, will step down as Board Chair of the global nonprofit HCP Cureblindness (Himalayan Cataract Project), but will maintain an active role on the Board as Medical Director. Long-time HCP volunteer and Board Member, Matt Oliva, MD, will lead HCP into its excitin
- Azura Ophthalmics Enrolls First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with MGDhttps://modernod.com/news/azura-ophthalmics-enrolls-first-patient-in-phase-3-clinical-trial-for-azr-md-001-in-patients-with-mgd/2482307/Azura Ophthalmics announced that the first patient has been enrolled in the ASTRO study—a phase 3 clinical trial assessing the efficacy and safety of AZR-MD-001 in patients with clinical signs and symptoms of meibomian gland dysfunction (MGD). "AZR-MD-001 has already dem
- 2024 Kavli Prize in Neuroscience Awarded for the Discovery of 'Face Areas' in the Brainhttps://modernod.com/news/2024-kavli-prize-in-neuroscience-awarded-for-the-discovery-of-face-areas-in-the-brain/2482322/The 2024 Kavli Prize in Neuroscience honors Nancy Kanwisher, PhD, (Massachusetts Institute of Technology); Doris Ying Tsao, PhD (University of California, Berkeley); and Winrich Freiwald, Ph.D. (Rockefeller University) for the discovery of a specialized system within the brain to r
- American Academy of Optometry Announces the 2023 Garlan W. Clay Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-the-2023-garlan-w-clay-award-recipients/2481798/The American Academy of Optometry has announced the recipients of the 2023 Garland W. Clay award: From the College of Optometry, The Ohio State University, Columbus, Ohio: Donald O. Mutti, OD, PhD, FAAO Loraine T. Sinnott, PhD G. Lynn Mitchel
- Optometry and Vision Science Names New Editor-in-Chiefhttps://modernod.com/news/optometry-and-vision-science-announces-new-editor-in-chief/2481744/The American Academy of Optometry (AAO) announced that David Elliott, PhD, FCOptom, FAAO, is the new editor-in-chief of Optometry and Vision Science (OVS). Mr. Elliott succeeds Michael Twa, OD, PhD, FAAO, who is stepping down from the role after 7 years.
- Ludwin Monz Stepping Down as CEO of Carl Zeiss Meditechttps://modernod.com/news/ludwin-monz-stepping-down-as-ceo-of-carl-zeiss-meditec/2480316/President and CEO of Carl Zeiss Meditec AG Ludwin Monz, PhD, announced that he will not be accepting another term in office, and will be stepping down from his postion effective December 31, 2021. The supervisory board has appointed Markus Weber, PhD, as the new President and
- Oxurion NV Appoints Prof Alan Stitt as Chief Scientific Officerhttps://modernod.com/news/oxurion-nv-appoints-prof-alan-stitt-as-chief-scientific-officer/2478775/Oxurion has announced the appointment of Professor Alan Stitt, PhD, as the company’s Chief Scientific Officer (CSO), effective January 19, 2021. This appointment follows the retirement of current CSO Jean Feyen, PhD, who has served in this position since joining the company in 2013. Dr. Feyen wil
- Julia Haller, MD, Named CEO of Wills Eye Hospitalhttps://modernod.com/news/julia-haller-md-named-ceo-of-wills-eye-hospital/2482897/Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital, will also become the hospital's next Chief Executive Officer. Dr. Haller assumed the expanded leadership post on July 18, succeeding longtime CEO Joseph P. Bilson, who reti